RAD21 and breast cancer: Since our analysis showed that RAD21 expression strongly correlates with TOP2A expression in a number of breast cancer cell lines (see Figure 3), we assessed the sensitivity of RAD21 knockdown clones to etoposide, a topoisomerase II inhibitor and commonly used anti-cancer drug.